Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kate Noseworthy

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Biorxiv : the Preprint Server for Biology|June 6, 2025
The Modulation of the Blood-Brain Barrier by Focused Ultrasound Stimulates OligodendrogenesisKate Noseworthy, Joseph Silburt, Kullervo Hynynen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 30, 2022
Efficacy of gene delivery to the brain using AAV and ultrasound depends on serotypes and brain areasRikke Hahn Kofoed, Chinaza Lilian Dibia, Kate Noseworthy, et al.
Acta Neuropathologica Communications|July 11, 2026
The modulation of the blood-brain barrier by focused ultrasound stimulates oligodendrogenesisKate Noseworthy, Joseph Silburt, Alessia Apa, et al.
Molecular Therapy. Methods & Clinical Development|October 26, 2022
The engineered AAV2-HBKO promotes non-invasive gene delivery to large brain regions beyond ultrasound targeted sitesRikke Hahn Kofoed, Kate Noseworthy, Kathleen Wu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisKate Noseworthy, Joseph Silburt, Laura M Vecchio, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 15, 2026
Focused ultrasound expands intra-CSF AAV delivery to deep brain regions in rats and non-human primatesRikke Hahn Kofoed, Bradford Elmer, Kate Noseworthy, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Biorxiv : the Preprint Server for Biology|June 6, 2025
The Modulation of the Blood-Brain Barrier by Focused Ultrasound Stimulates OligodendrogenesisKate Noseworthy, Joseph Silburt, Kullervo Hynynen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 30, 2022
Efficacy of gene delivery to the brain using AAV and ultrasound depends on serotypes and brain areasRikke Hahn Kofoed, Chinaza Lilian Dibia, Kate Noseworthy, et al.
Acta Neuropathologica Communications|July 11, 2026
The modulation of the blood-brain barrier by focused ultrasound stimulates oligodendrogenesisKate Noseworthy, Joseph Silburt, Alessia Apa, et al.
Molecular Therapy. Methods & Clinical Development|October 26, 2022
The engineered AAV2-HBKO promotes non-invasive gene delivery to large brain regions beyond ultrasound targeted sitesRikke Hahn Kofoed, Kate Noseworthy, Kathleen Wu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisKate Noseworthy, Joseph Silburt, Laura M Vecchio, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 15, 2026
Focused ultrasound expands intra-CSF AAV delivery to deep brain regions in rats and non-human primatesRikke Hahn Kofoed, Bradford Elmer, Kate Noseworthy, et al.
Pageof 1